Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Effect on Clinical Outcomes Using Secure Text Messaging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02568514
Recruitment Status : Withdrawn
First Posted : October 6, 2015
Last Update Posted : April 10, 2017
Sponsor:
Information provided by (Responsible Party):
University of Pennsylvania

Brief Summary:
In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.

Condition or disease Intervention/treatment Phase
Congestive Heart Failure Diabetes Renal Failure Copd Device: Secure text messaging Not Applicable

Detailed Description:
Inpatient health care providers such as physicians and nurses spend up to one-third of their time communicating with other health care providers. Many of these communications have shifted mediums from handwritten notes and face-to-face conversations to phone calls and paging systems. More recently the rapid adoption of smartphones has led to the use of mobile-enabled technologies using smartphones such as text messaging and email. While these technologies may offer ease and fit better within the clinical workflow, they often send patient information through unsecure cellular or internet connections. Mobile secure text messaging may address these issues by encrypting data and allowing for asynchronous or synchronous communication between individual providers or groups of providers. In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Health Services Research
Official Title: Study of the Effect on Clinical Outcomes Using Secure Text Messaging
Study Start Date : August 2016
Estimated Primary Completion Date : March 2017
Estimated Study Completion Date : March 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Usual care
Patients admitted to hospital floors without any other intervention.
Experimental: Secure text messaging
Patients admitted to hospital floors on which physicians and other staff are able to communicate with each other (not to the patient) using mobile secure text messaging.
Device: Secure text messaging
A smartphone and web application that allows physicians and other health care professionals to communicate to each other by secure text message




Primary Outcome Measures :
  1. Change in length of stay [ Time Frame: 6 months ]
    Change in inpatient length of stay from baseline to 6 months

  2. Change in 30 day hospital readmissions [ Time Frame: 6 months ]
    Change in 30 day hospital readmissions from baseline to 6 months

  3. Change in inpatient mortality [ Time Frame: 6 months ]
    Change in inpatient mortality from baseline to 6 months


Secondary Outcome Measures :
  1. Change in Hospital Consumer Assessment of Healthcare Providers and Systems (HCAPs) scores [ Time Frame: 6 months ]
    Change in HCAP scores from baseline to 6 months



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Admission to one of the hospital floors or services in the study at the Hospital of the University of Pennsylvania

Exclusion Criteria:

  • Discharges against medical advice
  • Discharges to hospice

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02568514


Locations
Layout table for location information
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
Investigators
Layout table for investigator information
Principal Investigator: Mitesh Patel, MD, MBA, MS University of Pennsylvania
Layout table for additonal information
Responsible Party: University of Pennsylvania
ClinicalTrials.gov Identifier: NCT02568514    
Other Study ID Numbers: 823096
First Posted: October 6, 2015    Key Record Dates
Last Update Posted: April 10, 2017
Last Verified: April 2017
Keywords provided by University of Pennsylvania:
mhealth
text messaging
secure text messaging
communication
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases